Advisory Board: Bios
George Daley, MD, PhD Venture Partner, Chief Medical/Scientific Advisor
Dr. George Daley is an Associate Professor in the Departments of Biological Chemistry and Molecular Pharmacology and Pediatrics, Harvard Medical School, and a staff member in Hematology/Oncology at the Children's Hospital, Dana Farber Cancer Institute, and Brigham and Women's Hospital. Dr. Daley received a bachelor's degree magna cum laude from Harvard College, a Ph.D. in biology from MIT, and was only the twelfth individual in the history of Harvard Medical School to receive the M.D. degree summa cum laude. Dr. Daley trained in internal medicine, hematology, and oncology, and served as Chief Resident in Internal Medicine at the Massachusetts General Hospital. Dr. Daley was formerly Whitehead Fellow at the MIT-affiliated Whitehead Institute for Biomedical Research and Assistant Professor of Medicine at Harvard Medical School. His research into the molecular basis of human Chronic Myeloid Leukemia contributed to the development of the remarkably effective target-directed drug Gleevec. He has been elected to the American Society for Clinical Investigation, and to fellowship in the American Association for the Advancement of Science. Dr. Daley was an inaugural winner of the NIH Director's Pioneer Award, and received the Daland Prize from the American Philosophical Society for the outstanding achievement in patient-oriented clinical investigation. Dr. Daley has also received numerous awards from Harvard Medical School, the National Institutes of Health, the New England Cancer Society, the Burroughs Wellcome Fund, the Edward Mallinckrodt, Jr. Foundation, and the Leukemia and Lymphoma Society of America.